NASDAQ:GYRE | EBITDA Margin | GYRE THERAPEUTICS, INC.

Complete source-backed ebitda margin history.

Available history
2009-12-31 to 2026-03-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2026-03-31-38.56%
2025-12-312.08%
2025-03-3112.73%
2024-12-314.04%
2024-03-3131.23%
2023-12-31-336.43%
2023-03-3127.84%
2022-03-31-1837.28%
2021-12-31-827.79%
2021-03-31-1526.45%
2020-12-31-925.46%
2020-03-31-30.81%
2018-03-31-110766.67%
2017-12-31-1820.13%
2015-03-31-4865.00%
2014-12-31-1354.33%
2014-03-31-13433.33%
2013-12-3126064.52%
2013-03-31-227.97%
2012-12-31-2688.14%
2012-03-3111.45%
2011-12-31-50.25%
2011-03-3133.09%
2010-12-31-3.49%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-3111.98%
2024-12-3116.75%
2023-12-31-58.31%
2022-12-3110.06%
2021-12-31-1193.84%
2020-12-31-273.21%
2018-12-31-561216.67%
2017-12-31-2126.62%
2014-12-31-2483.27%
2013-12-31-252.03%
2012-12-31-10.24%
2011-12-31-7.44%
2010-12-3117.63%
2009-12-31-153.58%